VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+25.84%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$107M
AUM Growth
+$107M
(-5.6%)
Cap. Flow
-$4.37M
Cap. Flow
% of AUM
-4.11%
Top 10 Holdings %
Top 10 Hldgs %
66.39%
Holding
38
New
6
Increased
9
Reduced
4
Closed
7
Top Buys
| 1 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$4.09M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$3.58M |
| 3 |
InspireMD
NSPR
|
$2.27M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$1.63M |
| 5 |
Geron
GERN
|
$1.54M |
Top Sells
| 1 |
Immunocore
IMCR
|
$9.89M |
| 2 |
ADMA Biologics
ADMA
|
$4.7M |
| 3 |
Lantheus
LNTH
|
$4.2M |
| 4 |
Terns Pharmaceuticals
TERN
|
$1.42M |
| 5 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$1.37M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rezolute
RZLT
$619M
| $792K | 0.74% |
400,000
| – | – |
|
|
ELEV
27
DELISTED
Elevation Oncology
ELEV
| $756K | 0.7% |
+497,299
| New | +$756K |
|
|
INBX
28
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $649K | 0.6% |
+25,000
| New | +$649K |
|
29
Cullinan Oncology
CGEM
$445M
| $538K | 0.5% |
+50,000
| New | +$538K |
|
30
AirSculpt Technologies
AIRS
$403M
| – | – |
0
| – | – |
|
31
Bolt Biotherapeutics
BOLT
$9.85M
| – | – |
-140,000
| Closed | -$195K |
|
32
Collegium Pharmaceutical
COLL
$1.22B
| – | – |
-22,095
| Closed | -$530K |
|
33
SPDR Euro Stoxx 50 ETF
FEZ
$4.54B
| – | – |
0
| – | – |
|
|
34
Immunocore
IMCR
$1.62B
| – | – |
-200,000
| Closed | -$9.89M |
|
35
Disc Medicine
IRON
$2.07B
| – | – |
-12,269
| Closed | -$260K |
|
36
Sonida Senior Living
SNDA
$488M
| – | – |
-82,832
| Closed | -$562K |
|
|
37
Terns Pharmaceuticals
TERN
$609M
| – | – |
-120,000
| Closed | -$1.42M |
|
|
THRX
38
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| – | – |
-100,000
| Closed | -$888K |
|